Company
Overview
Leadership
Social Accountability
Technology
RJX Technology
Therapeutic Areas
Pipeline
Clinical Trials
Contact
Contact Us
Join Reven
News
Latest News
Research
Investor Portal
2018/10/25 Reven News Press
October 25, 2018
| Featured
SAD Cohort 5 Underway. SAD Cohort 5A doses subjects.
More Reven News Releases
|
More Research & Development